CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.330

+17.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Norton who wrote ()	3/17/2000 2:13:00 AM
From: bob zagorin	of 668

Here's an excerpt from the Feb. release announcing "Curis". I think it illustrates that Curis will be the kind if company that will be able to commercialize human genome discoveries. "...``Curis will be positioned to identify and successfully commercialize therapeutic opportunities derived from the human genome program,' said Doros Platika, MD, president and chief executive officer of Ontogeny who will serve as president and chief executive officer of Curis. ``The technologies at Curis will represent a powerful system to identify target genes that may restore function through repair and regeneration. Curis' technology platform has already identified protein, small molecule and stem cell product opportunities. The Company is further backed by leading corporate partners and sustainable financial strength, including near-term product revenue opportunities..."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next